• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素纳米系统会成为新冠治疗试验中下一个有前景的抗病毒替代方案吗?

Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?

作者信息

Dourado Douglas, Freire Danielle T, Pereira Daniel T, Amaral-Machado Lucas, N Alencar Éverton, de Barros André Luís Branco, Egito E Sócrates T

机构信息

Graduate Program in Pharmaceutical Nanotechnology, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil; Dispersed Systems Laboratory (LaSiD), Pharmacy Department, UFRN, Natal, Brazil.

Dispersed Systems Laboratory (LaSiD), Pharmacy Department, UFRN, Natal, Brazil.

出版信息

Biomed Pharmacother. 2021 Jul;139:111578. doi: 10.1016/j.biopha.2021.111578. Epub 2021 Apr 6.

DOI:10.1016/j.biopha.2021.111578
PMID:33848774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8023207/
Abstract

The COVID-19 has become of striking interest since the number of deaths is constantly rising all over the globe, and the search for an efficient treatment is more urgent. In light of this worrisome scenario, this opinion review aimed to discuss the current knowledge about the potential role of curcumin and its nanostructured systems on the SARS-CoV-2 targets. From this perspective, this work demonstrated that curcumin urges as a potential antiviral key for the treatment of SARS-CoV-2 based on its relation to the infection pathways. Moreover, the use of curcumin-loaded nanocarriers for increasing its bioavailability and therapeutic efficiency was highlighted. Additionally, the potential of the nanostructured systems by themselves and their synergic action with curcumin on molecular targets for viral infections have been explored. Finally, a viewpoint of the studies that need to be carried out to implant curcumin as a treatment for COVID-19 was addressed.

摘要

自全球死亡人数不断上升以来,新型冠状病毒肺炎(COVID-19)已引起人们极大的关注,寻找有效的治疗方法变得更加紧迫。鉴于这种令人担忧的情况,本观点综述旨在讨论姜黄素及其纳米结构系统在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)靶点上潜在作用的现有知识。从这个角度来看,这项工作表明,基于姜黄素与感染途径的关系,它有望成为治疗SARS-CoV-2的潜在抗病毒关键药物。此外,还强调了使用负载姜黄素的纳米载体来提高其生物利用度和治疗效果。此外,还探讨了纳米结构系统本身的潜力及其与姜黄素在病毒感染分子靶点上的协同作用。最后,阐述了为将姜黄素作为COVID-19的治疗方法而需要开展的研究观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/11c9a8a7e29d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/fe41c125c911/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/47cf2f07a0a9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/11c9a8a7e29d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/fe41c125c911/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/47cf2f07a0a9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e462/8023207/11c9a8a7e29d/gr2_lrg.jpg

相似文献

1
Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?姜黄素纳米系统会成为新冠治疗试验中下一个有前景的抗病毒替代方案吗?
Biomed Pharmacother. 2021 Jul;139:111578. doi: 10.1016/j.biopha.2021.111578. Epub 2021 Apr 6.
2
Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro.姜黄根及其生物活性成分姜黄素在体外有效中和 SARS-CoV-2。
Viruses. 2021 Sep 23;13(10):1914. doi: 10.3390/v13101914.
3
The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic.药物纳米技术在 COVID-19 大流行时期的作用。
Future Microbiol. 2020 Oct;15:1571-1582. doi: 10.2217/fmb-2020-0118. Epub 2020 Nov 20.
4
Optimization of Anti-SARS-CoV-2 Treatments Based on Curcumin, Used Alone or Employed as a Photosensitizer.基于姜黄素的抗 SARS-CoV-2 治疗的优化:单独使用或用作光敏剂。
Viruses. 2022 Sep 27;14(10):2132. doi: 10.3390/v14102132.
5
Nanomedicine to deliver biological macromolecules for treating COVID-19.纳米医学递送生物大分子治疗 COVID-19。
Vaccine. 2022 Jun 23;40(29):3931-3941. doi: 10.1016/j.vaccine.2022.05.068. Epub 2022 May 30.
6
Antiviral Mechanisms of Curcumin and Its Derivatives in Prevention and Treatment of COVID-19: A Review.姜黄素及其衍生物在预防和治疗 COVID-19 中的抗病毒机制:综述。
Adv Exp Med Biol. 2023;1412:397-411. doi: 10.1007/978-3-031-28012-2_21.
7
Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives.纳米技术增强姜黄素的治疗潜力:当前的观点。
Artif Cells Nanomed Biotechnol. 2018;46(sup1):1004-1015. doi: 10.1080/21691401.2018.1442345. Epub 2018 Feb 28.
8
Antiinflammatory Activities of Curcumin and Spirulina: Focus on Their Role against COVID-19.姜黄素和螺旋藻的抗炎活性:聚焦它们在对抗新冠病毒中的作用
J Diet Suppl. 2023;20(2):372-389. doi: 10.1080/19390211.2023.2173354. Epub 2023 Feb 2.
9
Curcumin nanoformulations: a future nanomedicine for cancer.姜黄素纳米制剂:癌症治疗的未来纳米医学
Drug Discov Today. 2012 Jan;17(1-2):71-80. doi: 10.1016/j.drudis.2011.09.009. Epub 2011 Sep 18.
10
Curcumin and Its Analogs as a Therapeutic Strategy in Infections Caused by RNA Genome Viruses.姜黄素及其类似物作为治疗 RNA 基因组病毒感染的策略。
Food Environ Virol. 2022 Jun;14(2):120-137. doi: 10.1007/s12560-022-09514-3. Epub 2022 Mar 29.

引用本文的文献

1
A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19.一项关于姜黄与生姜对新冠肺炎患者炎症生物标志物影响的三盲随机对照试验。
Sci Rep. 2025 Aug 21;15(1):30793. doi: 10.1038/s41598-025-16092-4.
2
Structure-Based Design and In-Silico Evaluation of Computationally Proposed Curcumin Derivatives as Potential Inhibitors of the Coronaviral PLpro Enzymes.基于结构的计算设计及虚拟评估姜黄素衍生物作为冠状病毒PLpro酶潜在抑制剂的研究
Pharmaceuticals (Basel). 2025 May 26;18(6):798. doi: 10.3390/ph18060798.
3
Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy.

本文引用的文献

1
Nanoparticle-Based Strategies to Combat COVID-19.基于纳米颗粒的抗击新冠病毒策略
ACS Appl Nano Mater. 2020 Aug 25;3(9):8557-8580. doi: 10.1021/acsanm.0c01978. eCollection 2020 Sep 25.
2
Correction to Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin.《肠道冠状病毒多靶点抑制剂的修正:基于姜黄素的抗病毒阳离子碳点》
ACS Appl Nano Mater. 2020 May 22;3(5):4913. doi: 10.1021/acsanm.0c00970. Epub 2020 Apr 24.
3
Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.
基于植物化学物质的纳米系统:抗病毒光动力疗法的最新进展与新兴应用
Nanomedicine (Lond). 2025 Feb;20(4):401-416. doi: 10.1080/17435889.2025.2452151. Epub 2025 Jan 23.
4
Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations.姜黄素的创新递送系统:探索纳米制剂和传统制剂
Pharmaceutics. 2024 May 9;16(5):637. doi: 10.3390/pharmaceutics16050637.
5
Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review.用于治疗利什曼病的载姜黄素纳米结构系统:综述
Beilstein J Nanotechnol. 2024 Jan 4;15:37-50. doi: 10.3762/bjnano.15.4. eCollection 2024.
6
Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis.姜黄素作为COVID-19中的抗病毒剂和免疫炎症调节剂:一项科学计量学分析。
Heliyon. 2023 Nov 2;9(11):e21648. doi: 10.1016/j.heliyon.2023.e21648. eCollection 2023 Nov.
7
Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies.脂质肽液晶纳米组装体对CREB的持续磷酸化作用。
Commun Chem. 2023 Nov 6;6(1):241. doi: 10.1038/s42004-023-01043-9.
8
Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2.姜黄素传递体负载温敏型鼻内原位凝胶作为 SARS-CoV-2 的新型抗病毒治疗策略。
Int J Nanomedicine. 2023 Oct 17;18:5831-5869. doi: 10.2147/IJN.S423251. eCollection 2023.
9
Spices and Biomarkers of COVID-19: A Mechanistic and Therapeutic Perspective.香料与 COVID-19 标志物:一种机制与治疗视角。
Adv Exp Med Biol. 2023;1412:375-395. doi: 10.1007/978-3-031-28012-2_20.
10
Targeting Spike Glycoprotein S1 Mediated by NLRP3 Inflammasome Machinery and the Cytokine Releases in A549 Lung Epithelial Cells by Nanocurcumin.纳米姜黄素靶向NLRP3炎性小体机制介导的刺突糖蛋白S1以及A549肺上皮细胞中的细胞因子释放
Pharmaceuticals (Basel). 2023 Jun 9;16(6):862. doi: 10.3390/ph16060862.
姜黄素的抗病毒和免疫调节活性:COVID-19预防性治疗的一个实例
Heliyon. 2021 Feb;7(2):e06350. doi: 10.1016/j.heliyon.2021.e06350. Epub 2021 Feb 22.
4
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.抗新冠病毒候选药物:天然产物在新型冠状病毒感染管理中的潜在生物学活性综述
J Tradit Complement Med. 2021 Mar;11(2):144-157. doi: 10.1016/j.jtcme.2020.12.001. Epub 2020 Dec 29.
5
Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial.口服纳米姜黄素制剂治疗轻至中度住院的冠状病毒病-19患者的疗效:一项开放标签非随机临床试验。
Phytother Res. 2021 May;35(5):2616-2623. doi: 10.1002/ptr.7004. Epub 2021 Jan 3.
6
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.纳米姜黄素对轻、重症 COVID-19 患者 Th17 细胞反应的免疫调节作用。
J Cell Physiol. 2021 Jul;236(7):5325-5338. doi: 10.1002/jcp.30233. Epub 2020 Dec 28.
7
Curcumin as an Antiviral Agent.姜黄素作为抗病毒药物。
Viruses. 2020 Oct 31;12(11):1242. doi: 10.3390/v12111242.
8
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.纳米姜黄素疗法,一种有前景的调节 COVID-19 患者炎症细胞因子的方法。
Int Immunopharmacol. 2020 Dec;89(Pt B):107088. doi: 10.1016/j.intimp.2020.107088. Epub 2020 Oct 20.
9
Coronavirus biology and replication: implications for SARS-CoV-2.冠状病毒的生物学与复制:对 SARS-CoV-2 的启示。
Nat Rev Microbiol. 2021 Mar;19(3):155-170. doi: 10.1038/s41579-020-00468-6. Epub 2020 Oct 28.
10
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.含姜黄素纳米胶束作为治疗补充剂治疗 COVID-19 患者的临床效果及治疗后免疫反应平衡变化:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 22;21(1):876. doi: 10.1186/s13063-020-04824-y.